in vivo and in vitro are not used inappropriately in my view in this post - reg's faith that the IL-2R potency assay wasn't used before though is clearly incorrect as any checking of the MSB submission to ODAC using the wayback machine can make clear - MSB has ALWAYS used both TNFR1 and Il2Ralpha.
JB1975- I am asking questions JB, seeking input from any experts who follow these threads. I thought a different type of potency assay- still using IL2 - but different in some form or other- had been used but then changed to another .
I don't mind being wrong- asking questions- seeking clarification etc.
The query I have - of learned posters - is something from a IL2Ra assay has been presented that led to the FDA and the company changing their course.
You have previously been dismissive of the assay - you are sticking to the same line- the main parties involved have overcome a stumbling block.
Some-one, besides me, is missing something
Silviu Itescu, Philip Krause, Eric Rose, Nicole Verdun, JB1975
Veni Vidi Vici
orNero fiddles cum Roma ardet
Well done to all Olympians- a special breed
Reg
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17893
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online